Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

2.

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

3.

More nonsmokers are getting lung cancer: Oncologist explains why

4.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

5.

Psychotropics Linked to Increased BMI, CVD Risk


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot